NovaBay Pharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
NovaBay Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2012 to Q3 2024.
  • NovaBay Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $22K, a 64.5% decline year-over-year.
  • NovaBay Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $227K, a 22% decline year-over-year.
  • NovaBay Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $291K, a 32.3% increase from 2022.
  • NovaBay Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $220K, a 76.4% decline from 2021.
  • NovaBay Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $933K, a 75.4% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $227K $22K -$40K -64.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $267K $55K -$9K -14.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $276K $60K -$15K -20% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $291K $90K $0 0% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 $291K $62K +$270K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $21K $64K -$90K -58.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $111K $75K -$109K -59.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $220K $90K -$27K -23.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 $247K -$208K -$432K -193% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $679K $154K -$142K -48% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $821K $184K -$112K -37.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $933K $117K -$56K -32.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $989K $224K +$48K +27.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $941K $296K +$170K +135% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $771K $296K +$239K +419% Jan 1, 2021 Mar 31, 2021 10-Q 2022-08-11
Q4 2020 $532K $173K +$30K +21% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 $502K $176K +$70K +66% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $432K $126K +$3K +2.44% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $429K $57K -$57K -50% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $486K $143K -$20K -12.3% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-29
Q3 2019 $506K $106K -$62K -36.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $568K $123K -$31K -20.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $599K $114K -$72K -38.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $671K $163K +$250K Oct 1, 2018 Dec 31, 2018 10-K 2021-03-25
Q3 2018 $421K $168K -$772K -82.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $1.19M $154K -$342K -69% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $1.54M $186K -$1.01M -84.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $2.54M -$87K -$611K -117% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-26
Q3 2017 $3.15M $940K +$230K +32.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $2.92M $496K +$226K +83.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $2.7M $1.19M +$946K +383% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $1.75M $524K +$151K +40.5% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-29
Q3 2016 $1.6M $710K +$489K +221% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $1.11M $270K -$233K -46.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 $1.34M $247K -$38K -13.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 $1.38M $373K +$107K +40.2% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-21
Q3 2015 $1.28M $221K -$31K -12.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $1.31M $503K +$256K +104% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 $1.05M $285K +$8K +2.89% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 $1.04M $266K Oct 1, 2014 Dec 31, 2014 10-K 2017-03-23
Q3 2014 $252K +$29K +13% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 $247K -$71K -22.3% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 $277K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q3 2013 $223K +$223K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 $318K +$304K +2171% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-31
Q3 2012 $0 Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 $14K Apr 1, 2012 Jun 30, 2012 10-Q 2012-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.